Merck KGaA

Merck Announces Q1 2026 Earnings Beat Expectations

J.P. Morgan analyst reiterates buy rating on Merck

Merck Starts Phase III ELOWEN Project to Treat Lupus Patients

Merck Completes Acquisition of JSR Life Sciences' Chromatography Business

Kepler Capital and DZ BANK AG Maintain Buy Rating for Merck's Stock

Merck releases 2026 fiscal outlook

VALO HEALTH Partners with Merck to Develop Parkinson's Treatments

Merck KGaA and Promega Collaborate on Drug Screening Technologies

Merck's Precem-TcT drug shows positive results in Phase I clinical trial

Merck KgaA Signs Agreement with US Government to Expand IVF Access

Merck and Opentrons Collaborate to Launch AAW Automated Detection Workstation

Merck's enpatoran Phase II Study B Group Shows Positive Results for SLE Treatment

Merck's Pimicotinib Obtains Marketing Approval in China

First Eagle Invests in Merck, Holding 5.12% Stake

Merck Announces Positive Phase III Trial Results for Pimicotinib in Treating Tenosynovial Giant Cell Tumor

Merck and imec Collaborate on Microphysiological System Platform

CFO of Merck in Germany Indicates Readiness to Deal with Tariffs

ALIZY

European shares rose on May 13, with the Stoxx 600 up 0.8% at 611.42 points, driven by mining stocks. The basic resources index surged 4.4% to a record high. Corporate profits are expected to grow 10.2% in Q1, the fastest pace in three years. Notable gains included Merck (+7.2%), Allianz (+1%), and ABN Amro (+8.6%). Despite these gains, the Stoxx index lags behind US and Asian markets due to lower exposure to AI stocks. Investors are also focused on geopolitical tensions affecting oil prices.

Businesstimes News

Allianz

Merck

Allianz SE

S&P 500

Infineon Technologies AG

Infineon Technologies

STMicroelectronics NV

STMicroelectronics N.V.

AIXTRON SE

Interactive Brokers

European shares lifted by miners and tech; Mideast in focus

MKKGY

Merck KGaA's shares rose approximately 8% after the company raised its fiscal 2026 guidance despite weak Q1 results. The new forecast anticipates net sales of €20.4-21.4 billion and EBITDA pre of €5.7-6.1 billion, up from previous estimates. The company confirmed its mid-term guidance, targeting annual organic sales growth in the mid-single-digit range. In Q1, net income fell to €659 million, with net sales down 2.8% to €5.134 billion. The stock was trading at €121.70, reflecting a 7.7% increase on the XETRA exchange.

rttnews

Merck KGaA Lifts FY26 Outlook, Backs Positive Mid-term View, Despite Weak Q1; Stock Gains

SFTBY

9984

SoftBank Group reported a net profit of 5.003 trillion yen ($31.74 billion) for the fiscal year, more than quadrupling its previous year's profit, largely due to $43.9 billion in gains from its investment in OpenAI. The company plans to invest an additional $30 billion in OpenAI, bringing its total investment to $64.6 billion. SoftBank's Vision Funds business also saw a profit of Y6.445 trillion, a significant turnaround from a loss last year. The stock has risen 37% this year amid increasing AI demand.

MorningStar

SoftBank

SoftBank Group Corp.

OpenAI

NVIDIA

Deutsche Telekom AG

Deutsche Telekom

PayPay

Nasdaq

NVIDIA Corporation

SoftBank More Than Quadruples Annual Profit on $44 Billion in OpenAI Gains

.SPX

.NDX

U.S. stocks are expected to show mixed performance in early trading on Wednesday, following a weak previous session. Major index futures indicate a mixed open, with Nasdaq futures up 0.3%, while S&P 500 futures are down 0.1% and Dow futures down 0.5%. The Nasdaq may see gains due to strength in tech stocks, particularly Nvidia (NVDA).

- Stocks are projected to open mixed on Wednesday, following weakness in the previous session.  
- Nasdaq futures are up by 0.3 percent, while S&P 500 and Dow futures are down by 0.1 percent and 0.5 percent, respectively.  
- The Nasdaq's potential strength is attributed to positive movements among technology stocks, such as Nvidia (NVDA).

NASDAQ-100

Spdr Select Tech

ProShares Ultra QQQ

SPDR S&P 500

YieldMax NVDA Option Income Strategy ETF

GraniteShares 2x Long NVDA Daily ETF

Fidelity Nasdaq Composite Index ETF

Invesco Nasdaq 100 ETF

Pacer Cash COWZ 100-Nasdaq100RotatorETF

Proshares UltraPro QQQ

T-Rex 2X Long NVIDIA Daily Target ETF

Invesco QQQ Trust

NASDAQ Composite Index

Dow Jones Industrial Average

U.S. Stocks May Turn In Mixed Performance In Early Trading

European shares rose 0.7% on Wednesday, recovering from a previous drop, as oil prices fell amid stalled US-Iran peace negotiations. The pan-European STOXX 600 index reached 611.06 points. Regional markets, including Spain's IBEX 35 and Germany's DAX, also saw gains. Despite concerns over Middle East supply disruptions, European corporate profits are expected to rise 10.2% in Q1. Notable stock movements included Merck, which saw an 8% increase after raising its profit forecast, and Allianz, which rose 1.6% following a 52% increase in net profit for the quarter.

European shares rise as oil prices slip on fragile US-Iran ceasefire

Merck KGaA(MRK.DE)

European shares lifted by miners and tech; Mideast in focus

Merck KGaA Lifts FY26 Outlook, Backs Positive Mid-term View, Despite Weak Q1; Stock Gains

SoftBank More Than Quadruples Annual Profit on $44 Billion in OpenAI Gains

U.S. Stocks May Turn In Mixed Performance In Early Trading

European shares rise as oil prices slip on fragile US-Iran ceasefire